| mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.23 |
4e-06 |
| mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
5e-06 |
| mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
-0.21 |
1e-05 |
| mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-05 |
| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
3e-05 |
| mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
4e-05 |
| mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
5e-05 |
| mRNA |
TL-1-85 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
5e-05 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
6e-05 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
6e-05 |